STOCK-BASED COMPENSATION PLANS (Tables)

9 Months Ended

Sep. 30, 2023

STOCK-BASED COMPENSATION PLANS

Schedule of outstanding and exercisable number of options

	Outstanding	Exercisable
	Number of Options	Number of Options
	Outstanding Number of Options	Exercisable Number of Options
	(in thousands)	(in thousands)
Plan Category
2005 Stock Option Plan	211	211
2017 Stock Option Plan	351	351
Total	562	562

Schedule of stock-based compensation expenses recorded in the condensed consolidated statements of operations

The following summarizes stock-based compensation expenses recorded in the condensed consolidated statements of income (in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of Revenue	$	10	$	13	$	26	$	40
Sales and marketing expense		53		16		182		130
General, and administrative		591		549		1,413		1,532
Total stock based compensation expense	$	654	$	578	$	1,621	$	1,702

Schedule of stock option activity under all equity compensation plans

				Weighted-
		Weighted-		Average	Aggregate
	Number of	Average		Remaining	Intrinsic
	Shares	Exercise		Contractual	Value
	(in thousands)	Price		Term (Years)	(in thousands)
Outstanding at December 31, 2022	793	$	2.67	5.03	$	8,908
Granted	—	$	—
Forfeited	(206)	$	6.30
Exercised	(25)	$	5.36
Outstanding at September 30, 2023	562	$	1.22	2.80	$	3,807
Exercisable at September 30, 2023	562	$	1.22	2.80	$	3,807

Schedule of restricted stock award activity under all equity compensation plans

	Number of
	Shares	Weighted Average
	(in thousands)	Grant Date Fair Value
Granted but not vested at December 31, 2022	431	$	11.92
Granted	223		9.88
Forfeited	(11)		11.71
Vested	(157)		11.90
Granted but not vested at September 30, 2023	486	$	11.82